The C-terminus of CBFβ-SMMHC is required to induce embryonic hematopoietic defects and leukemogenesis

Blood

Volumn 121, Issue 4, 2013, Pages 638-642

  Kamikubo, Yasuhiko ^a   Hyde, R Katherine ^a   Zhao, Ling ^a   Alemu, Lemlem ^a   Rivas, Cecilia ^a   Garrett, Lisa J ^a   Liu, P Paul ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE BINDING FACTOR BETA; HYBRID PROTEIN; MUTAGENIC AGENT; MYOSIN HEAVY CHAIN; TRANSCRIPTION FACTOR RUNX1;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; GENE EXPRESSION; HEMATOPOIESIS; HETEROZYGOSITY; HOMOZYGOSITY; IN VIVO STUDY; LEUKEMOGENESIS; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL;

EID: 84873041077     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-06-434688     Document Type: Article

References (26)

1. Liu P, Tarl:e SA, Hajra A, et al. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science. 1993;261(5124):1041-1044.
2. Castilla LH, Garrett L, Adya N, et al. The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia. Nat Genet. 1999;23(2):144-146.
3. Castilla LH, Wijmenga C, Wang Q, et al. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell. 1996;87(4):687-696.
4. Hyde RK, Kamikubo Y, Anderson S, et al. Cbfb/Runx1 repression-independent blockage of differentiation and accumulation of Csf2rb-expressing cells by Cbfb-MYH11. Blood. 2010;115(7):1433-1443.
5. Wang Q, Stacy T, Miller JD, et al. The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. Cell. 1996;87(4):697-708.
6. Niki M, Okada H, Takano H, et al. Hematopoiesis in the fetal liver is impaired by targeted mutagen-esis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor. Proc Natl Acad Sci U S A. 1997;94(11):5697-5702.
7. Sasaki K, Yagi H, Bronson RT, et al. Absence of fetal liver hematopoiesis in mice deficient in tran-scriptional coactivator core binding factor beta. Proc Natl Acad Sci U S A. 1996;93(22):12359-12363.
8. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing Jr. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 1996;84(2):321-330.
9. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive he-matopoiesis. Proc Natl Acad Sci U S A. 1996; 93(8):3444-3449.
10. Kuo YH, Landrette SF, Heilman SA, et al. Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia. Cancer Cell. 2006;9(1):57-68.
11. Adya N, Stacy T, Speck NA, Liu PP. The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates. Mol Cell Biol. 1998;18(12):7432-7443.
12. Kummalue T, Lou J, Friedman AD. Multimeriza-tion via its myosin domain facilitates nuclear localization and inhibition of core binding factor (CBF) activities by the CBFbeta-smooth muscle myosin heavy chain myeloid leukemia oncopro-tein. Mol Cell Biol. 2002;22(23):8278-8291.
13. Zhang L, D'Costa J, Kummalue T, Civin CI, Friedman AD. Identification of a region on the outer surface of the CBFbeta-SMMHC myeloid oncoprotein assembly competence domain critical for multimerization. Oncogene. 2006;25(55): 7289-7296.
14. Durst KL, Lutterbach B, Kummalue T, Friedman AD, Hiebert SW. The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain. Mol Cell Biol. 2003;23(2):607-619.
15. Lutterbach B, Hou Y, Durst KL, Hiebert SW. The inv(16) encodes an acute myeloid leukemia transcriptional corepressor. Proc Natl Acad Sci U S A. 1999;96(22):12822-12827.
16. Kamikubo Y, Zhao L, Wunderlich M, et al. Accelerated leukemogenesis by truncated CBF beta-SMMHC defective in high-affinity binding with RUNX1. Cancer Cell. 2010;17(5):455-468.
17. Kundu M, Chen A, Anderson S, et al. Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11. Blood. 2002;100(7):2449-2456.
18. Rhoades KL, Hetherington CJ, Rowley JD, et al. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis. Proc Natl Acad Sci U S A. 1996;93(21):11895-11900.
19. Wilson NK, Calero-Nieto FJ, Ferreira R, Gottgens B. Transcriptional regulation of haematopoietic transcription factors. Stem Cell Res Ther. 2011;2(1):6.
20. Shimada H, Ichikawa H, Nakamura S, et al. Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8: overex-pression of the TIS11b (ERF-1, cMG1) gene induces myeloid cell proliferation in response to G-CSF. Blood. 2000;96(2):655-663.
21. Puig-Kröger A, Sanchez-Elsner T, Ruiz N, et al. RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements. Blood. 2003;102(9): 3252-3261.
22. Puig-Kröger A, Lopez-Rodriguez C, Relloso M, et al. Polyomavirus enhancer-binding protein 2/core binding factor/acute myeloid leukemia factors contribute to the cell type-specific activity of the CD11a integrin gene promoter. J Biol Chem. 2000;275(37):28507-28512.
23. Zhao LJ, Wang YY, Li G, et al. Functional features of RUNX1 mutants in acute transformation of chronic myeloid leukemia and their contribution to inducing murine full-blown leukemia. Blood. 2012;119(12):2873-2882.
24. Bernardin-Fried F, Kummalue T, Leijen S, Collector MI, Ravid K, Friedman AD. AML1/RUNX1 increases during G1 to S cell cycle progression independent of cytokine-dependent phosphorylation and induces cyclin D3 gene expression. J Biol Chem. 2004;279(15):15678-15687.
25. van Riel B, Pakozdi T, Brouwer R, et al. A novel complex, RUNX1-MYEF2, represses hematopoi-etic genes in erythroid cells. Mol Cell Biol. 2012; 32(19):3814-3822.
26. Pencovich N, Jaschek R, Tanay A, Groner Y. Dynamic combinatorial interactions of RUNX1 and cooperating partners regulates megakaryocytic differentiation in cell line models. Blood. 2011; 117(1):e1-e14.